Advances in Nanocarriers for Drug Delivery and Targeting, 2nd Edition

Dear Colleagues,

Nanotechnology has emerged as an area of active investigation, especially regarding its applications in medicine. Among all these applications, nanocarrier-assisted drug delivery systems have gained increasing recognition in recent years for the development of pharmaceuticals that can be directed toward specific targets of the body to improve the therapeutic outcome while reducing side-effects.

Nanocarriers serve as viable and durable nanovehicles for the targeted delivery of bioactive compounds such as vaccines, genes, drugs, and other biomolecules, providing increased solubility and thus bioavailability, biocompatibility, physicochemical stability, protection from degradation, and controllable release profiles.

In addition, the modifiable surfaces of nanocarriers also expand their usability in different biomedical applications, especially in targeted therapy. Indeed, their modification can not only stabilize but also functionalize them to be responsive to different stimuli, improving their therapeutic efficacy.

In this Special Issue of Pharmaceutics, we invite research, and review articles that advance our knowledge of nanosized drug delivery systems. Topics include, but are not limited to, theoretical and experimental research on the synthesis and development of functionalized nanocarriers or nanoformulations with targeting potential, their physicochemical and biological characterization, nanoparticle interactions with the immune system, in vitro and in vivo studies, preclinical and clinical studies, as well as safety issues regarding their production, handling, and disposal. We look forward to receiving your contributions.

Dr. Eleftherios Halevas
Dr. Chrysoula Kokotidou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanosized systems
• drug encapsulation
• drug targeting
• surface functionalization
• biodistribution
• controlled release
• triggered release
• biological evaluation

• Advances in Nanocarriers for Drug Delivery and Targeting in Pharmaceutics (9 articles)